FilingReader Intelligence

Alivus Life Sciences reports strong first quarter earnings

August 1, 2025 at 01:19 PM UTC•By FilingReader AI

Alivus Life Sciences Limited reported profit after tax of ₹1,215.35 million for the first quarter ended June 30, 2025. Revenue from operations reached ₹6,018.46 million, with basic earnings per equity share of ₹9.91.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

Primary Source Document

Pursuant to Regulations 30 and 33 of the SEBI LODR, 2015, we wish to inform you that the Board at its meeting held today approved the unaudited Financial Results for the First Quarter ended ....August 1, 2025 at 01:01 PM UTC

Glenmark Life Sciences

BSE:GLS•Bombay Stock Exchange

RSS feed for Glenmark Life Sciences

News Alerts

Get instant email alerts when Glenmark Life Sciences publishes news

Free account required • Unsubscribe anytime

Browse RSS Feeds

Filing Activity Timeline

View Complete Filing History →